In the context of a Lanham Act case, CRA assessed whether market performance for a hospital-based pharmaceutical product was affected by alleged improper statements by a competitor. CRA’s causality analysis included consideration of other economic factors that affected product sales, including assessment of market preparation, launch, commercialization, and promotional efforts used to support the product that was allegedly affected by improper marketing support.
Great Thinkers in Marketing series features two chapters from CRA Competition expert
Two academic articles co-authored by CRA’s Dr. Tolga Bilgicer (as the lead author) have been published as two separate chapters in The Research Contributions...